Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy [Phase 3]
Phase 3 study evaluating REGN5713-5715 for reducing signs and symptoms of ocular allergy in adults with birch pollen allergy (allergic conju…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy [Phase 3]
A Phase 3 study evaluating Bet v1 antibodies for eye allergy symptoms in adolescents and adults with birch pollen allergy. The trial is curr…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo [NA]
The clinical trial comparing Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops to placebo has completed. It studied allergic rhinitis …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization [NA]
A completed clinical trial from Inmunotek S.L. focusing on standardizing Phleum pratense and Dactylis glomerata allergen extracts for pollen…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies [Phase 2]
Phase 2 trial results for VSJ-110 in adults with allergic conjunctivitis, reporting safety and efficacy data. Results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy [Phase 3]
This update confirms the completion of a Phase 3 study evaluating REGN1908-1909 for reducing ocular allergy signs and symptoms in adults wit…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Documentation of Efficacy of Intralymphatic Allergen Immunotherapy [Phase 3]
Phase 3 clinical trial has completed and documents the efficacy of intralymphatic allergen immunotherapy for grass pollen–related allergic r…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction [Phase 4]
Phase 4 clinical trial comparing NAAGA to azelastine eye drops in subjects with allergic conjunctivitis and tear film dysfunction has been c…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution [Phase 3]
A Phase 3 trial evaluating the safety and pharmacokinetics of a fixed-dose combination Brimonidine tartrate 0.025% and Ketotifen fumarate 0.…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/Phase 2 methodology development environmental study of reproxalap in subjects with…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus [EARLY_Phase 1]
An early Phase 1 trial comparing intracanalicular dexamethasone insert to loteprednol etabonate in keratoconus patients to evaluate safety a…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Topical rVA576 for Treatment of Atopic Keratoconjunctivitis [Phase 1, Phase 2]
A Phase 1/2 study of topical rVA576 for atopic keratoconjunctivitis, vernal keratoconjunctivitis, and allergic conjunctivitis was terminated…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber [Phase 1, Phase 2]
This clinical trial update reports that the Reproxalap study in seasonal allergic conjunctivitis completed and results were posted on Februa…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of brimonidine tartrate and ketotifen fumarate for allergic conjunctivitis has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis [Phase 3]
Phase 3 ALLEVIATE trial in allergic conjunctivitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
This update covers completed clinical trials evaluating an artificial intelligence model designed to diagnose aeroallergies. The model aims …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) [Phase 4]
Phase 4 study evaluating the effects of desloratadine on ocular signs and symptoms after conjunctival allergen challenge in allergic conjunc…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of MDI-1228_mesylate ophthalmic solution in healthy adults, with the con…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study Of TL-925 For The Treatment of AC [Phase 2]
TL-925 was evaluated in a Phase 2 trial for allergic conjunctivitis, and the study has completed; the document does not disclose results in …
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations
A completed clinical trial from Federico II University evaluated dietary management of cow's milk allergy and whether these dietary choices …
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial update for INVIGORATE 2 evaluating efficacy and safety in seasonal allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis [Phase 2]
Phase 2 clinical trial update for NS2 in allergic conjunctivitis shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: A Study of TL-925 for the Treatment of Allergic Conjunctivitis [Phase 2]
Phase 2 clinical trial update for TL-925 in allergic conjunctivitis (status unknown).
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of a ketotifen 4.0% patch compared with placebo, olopatadine solution, and artificial tears…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children [Phase 3]
Phase 3 trial assessing bilastine ophthalmic solution in children for allergic conjunctivitis has completed.